retatrutide trial results A new clinical from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Don't Make This Mistake with

Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases

According to Transparency Market Research, the global GLP-1 analogues market size was valued at US$ 51.6 Bn in 2024 and is projected to reach US$ 211.8 Bn by 2035 , expanding at a CAGR of 13.7% from 2025 to 2035

Therefore, any research studies using these ingredients should be carefully designed to monitor for potential adverse reactions, and the concentration of these research compounds should be optimized to balance efficacy and safety

How Much Do GLP-1 Medications Cost in NYC

An uncontrolled trial in 32 participants with mild-to-moderate rosacea found a skincare regimen using three topical products (cleanser, daytime cream with sunscreen, and night cream) containing licochalcone A daily for eight weeks improved redness, skin texture, and telangiectasia